Illumina, Inc.ILMNNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank69
3Y CAGR-9.3%
5Y CAGR-21.0%
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-9.3%/yr
Quarterly compound
5Y CAGR
-21.0%/yr
Recent acceleration
Percentile
P69
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 20254.82%
Q3 2025-7.69%
Q2 2025-1.98%
Q1 2025-1.18%
Q4 20240.79%
Q3 2024-22.15%
Q2 2024-3.85%
Q1 2024-0.88%
Q4 20238.25%
Q4 2023-12.01%
Q3 20234.99%
Q2 2023-1.45%
Q4 20226.46%
Q4 2022-0.61%
Q3 20221.24%
Q2 2022-7.71%
Q4 2021-19.72%
Q4 2021115.84%
Q3 20212.54%
Q2 2021-1.01%
Q4 202015.70%
Q3 202010.97%
Q2 2020-0.64%
Q1 2020-3.11%
Q4 20196.62%
Q3 2019-9.04%
Q2 2019-1.78%
Q1 2019-3.98%
Q4 201810.69%
Q3 20185.30%
Q3 201810.22%
Q2 20180.00%
Q4 20172.24%
Q4 20173.08%
Q3 2017-10.34%
Q2 201711.61%
Q4 20163.18%
Q4 20161.07%
Q3 20160.48%
Q2 20168.44%